Similar articles for PMID: 28084977

Year	Number of Results
2003	1
2004	1
2005	7
2006	3
2007	2
2009	3
2010	18
2011	17
2012	14
2013	18
2014	22
2015	16
2016	8
2017	11
2018	13
2019	7
2020	12
2021	4
2022	12
2023	3
2024	0

1

What is the role of roflumilast in chronic obstructive pulmonary disease?

Lau C, Mehta AC, Hatipoglu U. Lau C, et al. Cleve Clin J Med. 2017 Jan;84(1):13-15. doi: 10.3949/ccjm.84a.15150. Cleve Clin J Med. 2017. PMID: 28084977 Free article. Review. No abstract available.

2

[Phosphodiesterase-4 inhibitors: a new target in treatment of COPD].

Michels G, Erdmann E, Pfister R. Michels G, et al. Dtsch Med Wochenschr. 2011 Nov;136(44):2267-70. doi: 10.1055/s-0031-1292040. Epub 2011 Oct 25. Dtsch Med Wochenschr. 2011. PMID: 22028292 Review. German.

3

Roflumilast (Daliresp) for COPD.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2011 Jul 25;53(1369):59-60. Med Lett Drugs Ther. 2011. PMID: 21778965 No abstract available.

4

Roflumilast for severe COPD?

[No authors listed] [No authors listed] Drug Ther Bull. 2011 Apr;49(4):45-8; quiz iii-iv. doi: 10.1136/dtb.2011.02.0025. Drug Ther Bull. 2011. PMID: 21467576 Review.

5

Reduce disease burden and improve lung function-roflumilast: approved for moderate to severe COPD: update for the clinical nurse specialist.

O'Malley P. O'Malley P. Clin Nurse Spec. 2011 Jul-Aug;25(4):176-7. doi: 10.1097/NUR.0b013e31822229a9. Clin Nurse Spec. 2011. PMID: 21654371 No abstract available.

6

Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.

Martinez FJ, Calverley PM, Goehring UM, Brose M, Fabbri LM, Rabe KF. Martinez FJ, et al. Lancet. 2015 Mar 7;385(9971):857-66. doi: 10.1016/S0140-6736(14)62410-7. Epub 2015 Feb 13. Lancet. 2015. PMID: 25684586 Clinical Trial.

7

Efficacy and safety of roflumilast in patients with stable chronic obstructive pulmonary disease: a meta-analysis.

Yan JH, Gu WJ, Pan L. Yan JH, et al. Pulm Pharmacol Ther. 2014 Feb;27(1):83-9. doi: 10.1016/j.pupt.2013.04.004. Epub 2013 Apr 23. Pulm Pharmacol Ther. 2014. PMID: 23624309

8

Clinical Considerations for Roflumilast: A New Treatment for COPD.

Kelly Freeman ML. Kelly Freeman ML. Consult Pharm. 2012 Mar;27(3):189-93. doi: 10.4140/TCP.n.2012.189. Consult Pharm. 2012. PMID: 22421519

9

Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.

Pinner NA, Hamilton LA, Hughes A. Pinner NA, et al. Clin Ther. 2012 Jan;34(1):56-66. doi: 10.1016/j.clinthera.2011.12.008. Clin Ther. 2012. PMID: 22284994 Review.

10

[Roflumilast: clinical review of a new option for the treatment of inflammation in COPD].

Martínez FJ. Martínez FJ. Arch Bronconeumol. 2010 Nov;46 Suppl 9:8-11. doi: 10.1016/S0300-2896(10)70047-8. Arch Bronconeumol. 2010. PMID: 21320811 Review. Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year